Home / NTAQ1 Knockout Cell Lines

NTAQ1 Knockout Cell Lines

Gene: NTAQ1

Official Full Name: N-terminal glutamine amidase 1provided by HGNC

Gene Summary: Predicted to enable protein-N-terminal glutamine amidohydrolase activity. Predicted to be involved in protein modification process. Predicted to be located in cytoplasm. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO15602 NTAQ1 Knockout cell line (HeLa) Human NTAQ1 1:3~1:6 Negative Online Inquiry
KO15603 NTAQ1 Knockout cell line (HCT 116) Human NTAQ1 1:2~1:4 Negative Online Inquiry
KO15604 NTAQ1 Knockout cell line (HEK293) Human NTAQ1 1:3~1:6 Negative Online Inquiry
KO15605 NTAQ1 Knockout cell line (A549) Human NTAQ1 1:3~1:4 Negative Online Inquiry

Background

NTAQ1 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of NTAQ1 gene function and its associated biological pathways. These cell lines are generated through advanced CRISPR/Cas9 gene-editing technology, resulting in complete knockout of the NTAQ1 gene, allowing researchers to investigate the contributions of this gene to various physiological and pathological processes.

The key function of NTAQ1 Knockout Cell Lines lies in their ability to provide insights into the gene's role in metabolic regulation, cellular signaling, and disease mechanisms. By examining these knockout models, scientists can elucidate how the absence of NTAQ1 impacts cellular behavior, including alterations in metabolic pathways or cellular stress responses. This information is critical in the context of diseases, especially metabolic disorders, where NTAQ1 may play a pivotal role.

The scientific importance of these cell lines extends to various research and clinical applications. They serve as invaluable tools for drug discovery, enabling researchers to screen for potential therapeutic compounds that target pathways influenced by NTAQ1. Furthermore, NTAQ1 Knockout Cell Lines can aid in understanding patient-specific disease mechanisms, ultimately contributing to personalized medicine approaches.

What sets these cell lines apart from traditional models is their precision, reliability, and ability to mirror in vivo conditions closely. Unlike conventional knockout methods, which may introduce off-target effects, the CRISPR/Cas9 technology used here ensures a high level of specificity and efficiency.

For researchers and clinicians focusing on metabolic research, cancer studies, or genetic disorders, the NTAQ1 Gene Knockout Cell Lines offer a clear advantage: a streamlined approach to dissecting gene function with robust reproducibility in experimental outcomes. This facilitates timely discoveries that can translate into impactful therapies or biomedical advancements.

Our company specializes in the development and provision of high-quality biological products tailored to meet the evolving needs of the research community. With a focus on innovation and accuracy, we are dedicated to supporting scientists in their quest to unlock the complexities of human biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.